(Q43070634)

13 November 2017

1 reference

title

Structure-activity relationship studies of dynorphin A and related peptides (English)

1 reference

13 November 2017

0 references

Naqvi T

1

1 reference

13 November 2017

Haq W

series ordinal

2

1 reference

13 November 2017

Mathur KB

series ordinal

3

1 reference

13 November 2017

publication date

1 January 1998

1 reference

13 November 2017

number of pages

16

1 reference

inferred from page(s)

published in

Peptides

1 reference

13 November 2017

volume

19

1 reference

13 November 2017

issue

7

1 reference

13 November 2017

page(s)

1277-1292

1 reference

Synthesis and Opioid Activity of Conformationally Constrained Dynorphin A Analogs. 1. Conformational Constraint in the "Message" Sequence

13 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Synthesis and Opioid Activities of (D-Leu8)Dynorphin(1-8) Analogs Containing a Reduced Peptide Bond, .PSI.(CH2NH)

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Specific receptor for the opioid peptide dynorphin: structure--activity relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Dynorphin Is a Specific Endogenous Ligand of the κ Opioid Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

N-terminal alkylated derivatives of [D-Pro10]dynorphin A-(1-11) are highly selective for kappa-opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

A peptide-like substance from pituitary that acts like morphine. 2. Purification and properties

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Activity-dependent neuronal plasticity following tissue injury and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Preferred conformation, orientation, and accumulation of dynorphin A-(1-13)-tridecapeptide on the surface of neutral lipid membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Isolation and amino acid sequence analysis of a 4,000-dalton dynorphin from porcine pituitary

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

D-PRO10dynorphin-(1–11) is a highly potent and selective ligand for ϰ opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

125I-DPDYN, monoiodo[D-Pro10]dynorphin(1-11): a highly radioactive and selective probe for the study of kappa opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Synthesis and biological activities of dynorphin A analogues with opioid antagonist properties

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Dynorphin-(1-13), an extraordinarily potent opioid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Antinociceptive profile of dynorphin in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Direct microsequence analysis of polypeptides using an improved sequenator, a nonprotein carrier (polybrene), and high pressure liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Recent developments in the design of receptor specific opioid peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Enhancement of phagocytosis by dynorphin A in mouse peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Design and synthesis of highly potent and selective cyclic dynorphin A analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Design and synthesis of highly potent and selective cyclic dynorphin A analogs. 2. New analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Properties of a selective kappa agonist, U-50,488H

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

[3H]U-69593 a highly selective ligand for the opioid kappa receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Mass spectrometric identification of various molecular forms of dynorphin in bovine adrenal medulla

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Synthesis and biological activity of dynorphin-(1-13) and analogs substituted in positions 8 and 10.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Synthesis and biological activity of analogs of dynorphin-A(1-13) substituted in positions 2 and 4: design of [Ala2,Trp4]-Dyn-A(1-13) as a putative selective opioid antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Effects of modifications of residues in position 3 of dynorphin A(1-11)-NH2 on kappa receptor selectivity and potency

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Solution conformations of the pituitary opioid peptide dynorphin-(1–13)

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Comparison of in vitro potencies in pharmacological and binding assays after inhibition of peptides reveals that dynorphin (1–9) is a potent κ-agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Design, synthesis, and biological properties of highly potent cyclic dynorphin A analogues. Analogues cyclized between positions 5 and 11.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Synthesis using a Fmoc-based strategy and biological activities of some reduced peptide bond pseudopeptide analogues of dynorphin A1.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Kappa-opioid receptors and analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Dynorphin (1–13): Analgesia, hypothermia, cross-tolerance with morphine and β-endorphin

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Edward E. Smissman-Bristol-Myers Squibb Award Address. The role of concepts in structure-activity relationship studies of opioid ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Chemical structures and biological activities of non-peptide selective kappa opioid ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

The effects of a non-competitive NMDA receptor antagonist, MK-801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Dynorphin A (1-13) peptide NH groups are solvent exposed: FT-IR and 500 MHz 1H NMR spectroscopic evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Opioid-like properties of seven dynorphin (1–10) analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Fluorescence study on the solution conformation to dynorphin in comparison of enkephalin.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Comparative structure-function studies with analogs of dynorphin-(1–13) and [Leu5] enkephalin

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Estimated conformation, orientation, and accumulation of dynorphin A-(1-13)-tridecapeptide on the surface of neutral lipid membranes.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Non-opioid effects of dynorphins: possible role of the NMDA receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Opioid receptors and endogenous opioid peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Synthesis and opioid activity of dynorphin A-(1-13)NH2 analogues containing cis- and trans-4-aminocyclohexanecarboxylic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Effect of modification of the basic residues of dynorphin A-(1-13) amide on kappa opioid receptor selectivity and opioid activity

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Synthesis and opioid activity of 2-substituted dynorphin A-(1-13) amide analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Isolation and structure of dynorphin, an opioid peptide, from porcine duodenum

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Peptide models of dynorphin A(1-17) incorporating minimally homologous substitutes for the potential amphiphilic beta strand in residues 7-15.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

U-50,488, a selective kappa opioid agonist: Comparison to other reputed kappa agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Nonopiate effects of dynorphin and des-Tyr-dynorphin.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

[D-Ala2, (F5) Phe4]-dynorphin 1-13-NH2 (DAFPHEDYN): a potent analog of dynorphin 1-13.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Immunomodulating peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Intrathecal administration of beta-endorphin and dynorphin-(1-13) for the treatment of intractable pain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Synthesis and structure-activity relationships of dynorphin A-(1-8) amide analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

Synthesis and biological activity of [MeTyr1,MeArg7,D-Leu8]-dynorphin A(1-9)-NHEt and [D-Cys2-Cys5,MeArg7,D-Leu8]-dynorphin A(1-9)-NH2

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900042-4

7 January 2021

10.1016/S0196-9781(98)00042-4

Identifiers

DOI

1 reference

13 November 2017

1 reference